TP53 and breast cancer: Recent publications have described the germline molecular epidemiology of BC in Brazil, demonstrating unique genetic features such as the Brazilian TP53 R337H variant, detected in 1.6% of BC patients and 0.1% of reference controls, strongly associated with risk of BC (OR = 17.4, p<0.0001) (20).